The US Food and Drug Administration had lifted a clinical hold on Advaxis Inc’s 3 experimental cancer therapies, as per an announcement made by the drug developer on Wednesday. This has boosted the shares of the company by nearly 38%.
In October, the US health regulator had put the mid-...read more
The overall ‘asthma epidemic’ among children has...Read More
People in huge numbers gathered in the Mount Lofty...Read More
As New Year is approaching, people have already...Read More
Alzheimer’s disease, the commonest cause of...Read More
Cases of opioid abuse have been increasing and...Read More
In an announcement made on December 22, cable giant...Read More